Lv1
20 积分 2022-12-11 加入
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
1个月前
已完结
MHC Class I Loss in Triple-negative Breast Cancer
1个月前
已完结
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
1个月前
已完结
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants
1个月前
已完结
Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density
1个月前
已完结
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
1个月前
已完结
PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway
1个月前
已完结
Regulation of differentiation of vascular smooth muscle cells
1个月前
已完结
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
1个月前
已完结
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature
1个月前
已完结
皖公网安备34019202002308
